Loading...

Invesco Dynamic Biotechnology & Genome ETF

PBEAMEX
Financial Services
Asset Management
$63.97
$-0.40(-0.63%)

Invesco Dynamic Biotechnology & Genome ETF PBE Peers

See (PBE) competitors and their performances in Stock Market.

Peer Comparison Table: Asset Management Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PBE$63.97-0.63%291.1M20.69$3.09+0.07%
VFINX$563.77+1.11%1.5T26.54$21.24+1.25%
VOO$559.77+0.06%1.4T26.56$21.07+1.25%
VITSX$145.90+1.15%1.2T25.81$5.65+1.32%
VTSAX$145.88+1.15%1.2T25.81$5.65+1.24%
FXAIX$212.14+1.11%647.1BN/AN/AN/A
VTI$299.45-0.09%621B25.80$11.61+1.25%
IVV$610.00+0.08%584.9B26.25$23.24+1.31%
SPY$607.09+0.05%557.2B26.24$23.13+1.18%
VTSNX$146.20+1.58%500.5B16.29$8.97+2.87%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

PBE vs VFINX Comparison

PBE plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBE stands at 291.1M. In comparison, VFINX has a market cap of 1.5T. Regarding current trading prices, PBE is priced at $63.97, while VFINX trades at $563.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBE currently has a P/E ratio of 20.69, whereas VFINX's P/E ratio is 26.54. In terms of profitability, PBE's ROE is +0.00%, compared to VFINX's ROE of +0.00%. Regarding short-term risk, PBE is more volatile compared to VFINX. This indicates potentially higher risk in terms of short-term price fluctuations for PBE.

Stock Price Comparison

Loading...

Frequently Asked Questions

;